Abstract
NSAIDs are the current mainstay of treatment for gout flares, despite being associated with an increased risk of gastrointestinal bleeding and cardiovascular events. Janssens et al. conducted a randomized, double-blind, equivalence clinical trial to determine whether the glucocorticoid prednisolone can be used as an alternative to NSAIDs in this setting. Patients referred from primary care community clinics with monosodium urate crystal-proven acute gout flares (n =120) underwent treatment with once-daily oral prednisolone 35 mg or twice-daily oral naproxen 500 mg for 5 days. The results revealed a nonsignificant difference between the two groups, both in the primary outcome measure of pain reduction and in the secondary outcomes of disability related to the affected joint and walking, suggesting equivalence between the two agents. This study helps to position oral glucocorticoids as effective and safe alternatives in the management of acute gout flares. Future studies should address the treatment of acute gout in elderly populations and in those with multiple comorbidities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Harris CM et al. (1995) The prevalence and prophylaxis of gout in England. J Clin Epidemiol 48: 1153–1158
Lawrence RC et al. (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58: 26–35
Janssens HJ et al. (2008) Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomized equivalence trial. Lancet 371: 1854–1860
Zhang W et al. (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1312–1324
Man CY et al. (2007) Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 49: 670–677
Piaggio et al. (2006) Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295: 1152–1160
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K G Saag has consulted to and received grants/research support from TAP (Takeda) and Novartis, and has consulted to Savient. AL Gaffo declared no competing interests.
Rights and permissions
About this article
Cite this article
Gaffo, A., Saag, K. Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?. Nat Rev Rheumatol 5, 12–13 (2009). https://doi.org/10.1038/ncprheum0962
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0962